LONG-TERM PROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN GENERAL-SURGERY - EFFECT ON COAGULATION AND FIBRINOLYSIS

被引：0
|
作者：
JORGENSEN, LN
WALENGA, JM
LAUSEN, I
HOPPENSTEADT, D
MORAN, S
WILLEJORGENSEN, P
RASMUSSEN, MS
HAUCH, O
LYNG, KM
ANDERSEN, M
JENSEN, R
机构：
[1] BISPEBJERG HOSP,DEPT SURG GASTROENTEROL,DK-2400 COPENHAGEN,DENMARK
[2] BISPEBJERG HOSP,DEPT THORAC SURG,DK-2400 COPENHAGEN,DENMARK
[3] BISPEBJERG HOSP,DEPT RADIOL,DK-2400 COPENHAGEN,DENMARK
[4] LOYOLA MED CTR,DEPT THORAC CV SURG,MAYWOOD,IL
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1117 / 1117
页数：1
相关论文
共 50 条
  • [31] Long-term Low-molecular-weight Heparin Therapy during Pregnancy: Is There a Bone Risk?
    Khalifa, Pierre
    Marie-Scemama, Lydia
    THERAPIE, 2013, 68 (01): : 37 - 42
  • [32] Treatment of a patient with an undefined hypercoagulable state with long-term low-molecular-weight heparin
    Dobie, SA
    Ellsworth, AJ
    Linenberger, ML
    WESTERN JOURNAL OF MEDICINE, 1996, 164 (04): : 350 - 353
  • [33] Treatment-resistant priapism associated with long-term low-molecular-weight heparin
    Bouchier-Hayes, David
    Nolan, Philip
    Pate, Gordon
    BMJ CASE REPORTS, 2021, 14 (04)
  • [34] Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism
    Javier Marchena, Pablo
    Antonio Nieto, Jose
    Guil, Maria
    Garcia-Bragado, Ferran
    Rabunal, Ramon
    Boccalon, Henri
    Trujillo-Santos, Javier
    Monreal, Manuel
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (01) : 37 - 43
  • [35] EFFECTS OF A LOW-MOLECULAR-WEIGHT HEPARIN (LMWH, FRAGMIN(R) AND OF UNFRACTIONATED HEPARIN (UFH) ON COAGULATION AND PLATELET ACTIVATION IN-VIVO
    EICHINGER, S
    WOLZT, M
    EICHLER, HG
    LECHNER, K
    KYRLE, PA
    BLOOD, 1993, 82 (10) : A147 - A147
  • [36] DOSE DEPENDENT SUPPRESSION OF MINERALOCORTICOID PRODUCTION (MP) BY LOW-DOSE HIGH-MOLECULAR-WEIGHT HEPARIN (UFH) AND LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PROPHYLAXIS
    SIEBELS, M
    ANDRASSY, K
    VECSEI, P
    SEELIG, HP
    WEBER, E
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 925 - 925
  • [37] DOSES DETERMINATION FOR THE LOW-MOLECULAR-WEIGHT HEPARIN FRACTION (LMWH) KABI 2165 IN THE SUBCUTANEOUS PERIOPERATIVE THROMBOSIS PROPHYLAXIS
    BRAUN, B
    KIEHL, R
    HELLSTERN, P
    WENZEL, E
    HAEMOSTASIS, 1986, 16 : 144 - 144
  • [38] EFFECT OF A LOW-MOLECULAR-WEIGHT HEPARIN, CALCIUM NADROPARINE (CY216), ON FIBRINOLYSIS IN PATIENTS UNDERGOING SURGERY
    POGLIANI, EM
    SALVATORE, M
    BARAGETTI, I
    SETTEMBRINI, PG
    PEZZUOLI, G
    POLLI, EE
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 53 (02): : 180 - 187
  • [39] LOW-MOLECULAR-WEIGHT HEPARIN IN THE PROPHYLAXIS AND TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA
    GILLIS, S
    DANN, EJ
    ELDOR, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (01) : 59 - 60
  • [40] COAGULATION PARAMETERS AND INHIBITORS IN THE HEPARIN-PROPHYLAXIS OF THROMBOSIS - COMPARISON BETWEEN UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN
    LORENZ, R
    BAUM, U
    BORN, P
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 967 - 967
12345